SecBot SecBot

GLPGF

Lakefront Biotherapeutics NV
OTC· Pharmaceutical Preparations· CIK 0001421876 Biotech & Drug Discovery
$31.95 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $31.95
1 year
−4.5%
from $33.45 · Oct 27
30 days
0.0%
from $31.95
52-week range
$26.24–34.00
−6% from high · low Aug 6
Avg volume 20D
0
Sep 29 spike 0
Short interest
🔒 Subscribers only
Filing reports
3
analyzed by SecBot
SecBot read MIXED 3 reports · latest
Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/3
Strongest NEUTRAL Lakefront Biotherapeutics (formerly Galapagos) announced a $50 million share repurchase program, authorized…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • TrendUPTREND

    10% above its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 9, 2026 SEC
Lakefront Biotherapeutics (formerly Galapagos) announced a $50 million share repurchase program, authorized through…
6-K — Impact 4/10
Jun 9, 2026 SEC
Lakefront Biotherapeutics appointed Eric Hedrick, MD, as Chief Medical Officer, effective June 8, 2026. Dr. Hedrick…
6-K — Impact 3/10
Apr 29, 2026 SEC
Galapagos NV held its Annual and Extraordinary Shareholders' Meetings on April 28, 2026, where all board-proposed…
6-K — Impact 2/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$41.2M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY———$84.6M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short

SecBot reports

3 filings · 0 bullish · 0 bearish · 3 neutral
All GLPGF filing & press-release reports (3)